Date
Title
October 01, 2018

Potential utility of a Positive EarlyCDT®—Lung Blood Biomarker Test in Indeterminate Pulmonary Nodules.

–Journal of Thoracic Oncology
September 30, 2018

Development and validation of an ELISA test detecting a panel of autoantibodies in combination with AFP for early detection of hepatocellular carcinoma

–ILCA, London
May 22, 2018

Cost-effectiveness of an autoantibody test (EarlyCDT®—Lung ) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules

–PLOS One
November 01, 2017

Determination of the detection lead time for autoantibody biomarkers in early stage lung cancer using the UKCTOCS cohort

–Journal of Thoracic Oncology
October 13, 2017

Changes in Smoking Behaviour in the Early Cancer Detection Test Lung Cancer Scotland (ECLS) Study

–Journal of Thoracic Oncology
October 12, 2017

Is Lung Cancer Screening Associated with a Negative Psychological Impact?

–Journal of Thoracic Oncology
October 03, 2017

How Does Screening for the Early Detection of Lung Cancer Facilitate Smoking Cessation? A Qualitative Study of Screened Smokers

–Journal of Thoracic Oncology
September 12, 2017

Autoantibodies as additive biomarkers to AFP for the detection of HCC

–11th Annual International Liver Cancer Association (ILCA)
September 01, 2017

An interim report on the detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®—Lung Test in Scotland (ECLS)

–European Respiratory Journal
May 01, 2017

Tumor-Associated Autoantibodies: Re-Optimization of EarlyCDT®—Lung Diagnostic Performance and Its Application to Indeterminate Pulmonary Nodules

–Journal of Cancer Therapy
March 27, 2017

Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography for Detection of Lung Cancer

–Journal of Thoracic Oncology
March 01, 2017

Detection in Blood of Autoantibodies to Tumour Antigens as a Case-Finding Method in Lung Cancer Using the EarlyCDT®—Lung Test (ECLS): Study Protocol for a Randomized Controlled Trial

–BMC Cancer
March 01, 2017

Autoantibodies: Opportunities for Early Cancer Detection

–Trends in Cancer
November 13, 2016

An RCT of the Detection of Autoantibodies to Tumor Antigens in Lung Cancer Using the EarlyCDT®—Lung Test in Scotland (ECLS) in 12 208 Study Subjects

–2016 IASLC
October 18, 2016

Analysis of the Early CDT-Blood Biomarker for Lung Cancer in Higher vs. Lower Risk Cohorts

–2016 IASLC
October 10, 2016

Improvement in Performance of an Autoantibody Panel Test for Detection of Lung Cancer by Addition of a Single Novel Biomarker (EDB1)

–2016 IASLC
September 21, 2015

Screening for Lung Cancer with the Early CDT-Lung and Computed Tomography

–Journal of Thoracic Oncology
September 07, 2015

Progress with an RCT of the Detection of Autoantibodies to Tumour Antigens in Lung Cancer Using the EarlyCDT®—Lung Test in Scotland (ECLS)

–Journal of Thoracic Oncology
May 19, 2015

Improvement in the Performance of the EarlyCDT®—LungTest in the Detection of Lung Cancer by the Application of Additional Metrics to Reduce False Positive Results

–2015 ATS Annual Meeting, Am J Respir Crit Care Med
May 18, 2015

Measuring the improvement in lung nodule cancer risk assessment when EarlyCDT®—Lung is applied to a clinically-tested high-risk cohort

–2015 ATS Annual Meeting, Am J Respir Crit Care Med
February 16, 2015

Development of a Serum Autoantibody Assay to Help with the Detection of Hepatocellular Carcinoma

–7th Annual International Liver Cancer Association (ILCA)
February 15, 2015

Serum Antibodies in Ovarian Cancer

–Molecular Med Tri-Con 2015
August 01, 2014

Serum Autoantibody Measurement for the Detection of Hepatocellular Carcinoma

–PLOS One
October 14, 2013

Autoantibodies to a panel of lung cancer-associated antigens can provide significant discrimination between malignant and non-malignant lung nodules

–WCLC 2013
October 01, 2013

Audit of the autoantibody test, EarlyCDT®—Lung, in 1600 patients: an evaluation of its performance in routine clinical practice

–Lung Cancer Journal
October 01, 2013

Signal stratification of autoantibody levels in serum samples and its application to the early detection of lung cancer

–Journal of Thoracic Disease
September 05, 2013

Changes in autoantibody profiles in individuals with, and at risk for, Hepatocellular Carcinoma

–7th Annual International Liver Cancer Association (ILCA)
September 01, 2013

An Audit of the Clinical Performance of EarlyCDT®—Lung

–Chicago Multidisciplinary Symposium in Thoracic Oncology (ASTRO)
August 23, 2013

Signal Stratification of Autoantibody Levels in Serum Samples and its Application to the Early Diagnosis of Lung Cancer

–Am J Respir Crit Care Med
December 01, 2012

Application of a High Throughput Method of Biomarker Discovery to Improvement of the EarlyCDT®—Lung Test

–PLOS One
November 01, 2012

Challenges in Biomarker Development

–World Breast Cancer Report 2012
October 24, 2012

Benefits of Using EarlyCDT®—Lung in Clinical Practice

–Chest
October 24, 2012

The Additive Effect of the Stratified EarlyCDT®—Lung Serum Autoantibody Test on the Assessment of Lung Cancer Risk

–Chest
October 21, 2012

EarlyCDT®—Lung enhances the positive predictive power of computed tomography for detecting lung cancer

–Chest
October 10, 2012

Early identification of hepatocellular carcinoma

–ISOBM 2012, Tumor Biology
October 05, 2012

Early identification of lung cancer using autoantibody assays

–40th Congress of the International-Society-of-Oncology-and-Biomarkers, Volume: 33
July 24, 2012

Development and Validation of a High Throughput System for Discovery of Antigens for Autoantibody Detection

–PLOS One
May 10, 2012

Identification of Tumor-Associated Autoantibodies to Different Forms of Recombinant MAGE A4

–Am J Respir Crit Care Med
May 01, 2012

Identification of Tumour-Associated Autoantibodies in Small-Cell Lung Cancer as Immune Markers of Disease

–ISOBM 2012, Tumor Biology
May 01, 2012

Improved Specificity of the EarlyCDT®—Lung Test Through Additional Autoantibody Assays

–Am J Respir Crit Care Med
April 01, 2012

EarlyCDT®—Lung test: improved clinical utility through additional autoantibody assays

–Tumour Biology
December 06, 2011

Serum autoantibodies to breast cancer associated antigens reflect tumour biology: an opportunity for early detection & prevention?

–Cancer Research Special Supplement
October 31, 2011

Autoantibodies as Immunobiomarkers in Lung Cancer and their use in Early Cancer Detection

–Tumor Biology Supplement
October 09, 2011

Autoantibodies to p53 can Predate a Clinical Diagnosis of Ovarian Cancer – A Case Report

–Tumor Biology Supplement
October 09, 2011

Autoantibodies in Ovarian Cancer

–Tumor Biology Supplement
September 05, 2011

The utility of SOX antibodies for cancer prediction in patients with paraneoplastic neurological disorders

–Association of British Neurologists Annual Meeting 2011
July 01, 2011

EarlyCDT®—Lung Test: Audit of the First 1000 Patients in Clinical Practice

–IASLT Amsterdam
May 18, 2011

Mesothlioma and tumor-associated autoantibodies

–Am J Respir Crit Care Med
May 17, 2011

Demonstration of the Specificity of Human Autoantibody Responses to Tumor Associated Antigens

–Am J Respir Crit Care Med
May 16, 2011

Cost-Effectiveness of Screening Older Adult Smokers for Lung Cancer with an Autoantibody Test (AABT)

–Am J Respir Crit Care Med
May 16, 2011

EarlyCDT®—Lung: A Newly Marketed Blood Test to Aid the Early Detection of Lung Cancer in High-Risk Patients – Enhances the Positive Predictive Power of Computed Tomography

–Am J Respir Crit Care Med
March 05, 2011

EarlyCDT®—Lung: an Immuno-biomarker Test as an Aid to Early Detection of Lung Cancer

–Cancer Prevention Research
December 11, 2010

Immuno-biomarkers in small cell lung cancer: Potential early clinical signals

–Clinical Cancer Research
December 01, 2010

An Improved EarlyCDT®—Lung Test Can Be Used to Aid the Detection of Lung Cancer

–Chicago Multidisciplinary Symposium in Thoracic Oncology (ASTRO)
October 11, 2010

Antigen Positivity in the Early CDT—Lung Test by Stage and Histological Subtype of Lung Cancer

–Chest
October 10, 2010

The Presence of Autoantibodies to Tumour-Associated Antigens can Predate Clinical Diagnosis of Lung Cancer (CHEST 2010)

–Chest
October 09, 2010

Autoantibodies in Oncology – presence and use for early disease identification

–XIII International Symposium on Biology and Clinical Usefulness of Tumor Markers – Barcelona
October 01, 2010

Stage 1a Non-Small Cell Lung Cancer Detected by Assaying Autoantibodies to Tumor Antigens

–Chest
October 01, 2010

EarlyCDT®—Lung: QC measures reveal high precision, accuracy and robustness of a clinical test to aid in early lung cancer detection for high-risk individuals

–Chest
October 01, 2010

An autoantibody test (AABT) to aid in early detection of lung cancer in high-risk patients is likely to be cost-effective

–Chest
October 01, 2010

Reproducibility of autoantibody measurements in normal individuals using the EarlyCDT®—Lung test

–Chest
September 19, 2010

The Presence of Autoantibodies to Tumour-Associated Antigens can Predate Clinical Diagnosis of Lung Cancer

–Tumor Biology Supplement
September 19, 2010

Does Heat Treatment of Human Serum Affect the Measurement of Autoantibodies to Recombinant Tumour-Associated Antigens?

–Tumor Biology Supplement
July 03, 2010

Clinical Validation of an Autoantibody Test for Lung Cancer

–Annals of Oncology
June 15, 2010

Demographics of Populations at High Risk of Lung Cancer and Results of the EarlyCDT®—Lung Test

– Journal of Clinical Oncology, ASCO
June 04, 2010

Cost-Effectiveness of an Autoantibody Test (AABT) as an Aid to Diagnosis of Lung Cancer

–Journal of Clinical Oncology, ASCO
June 04, 2010

Use of Serum Autoantibodies to Identify Early-Stage Lung Cancer: A Significant Step Forward in Early Detection

–Journal of Clinical Oncology, ASCO
May 12, 2010

Cancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancer

–PLOS One
April 29, 2010

Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer

–Lung Cancer Journal
February 17, 2010

Technical validation of an autoantibody test for lung cancer

–Annals of Oncology
September 24, 2008

A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression

–Glycobiology
August 30, 2008

Lung cancer – can autoantibodies provide an aid to diagnosis?

–Expert Opinion on Medical Diagnostics
March 30, 2008

Autoantibodies in lung cancer – possibilities for early detection and subsequent cure

–Thorax
March 01, 2008

The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient’s serum

–Glycobiology
January 01, 2008

Removal Of Major Bacterial Contaminant SlyD After A Two-Step Chromatography Purification Of Recombinant Protein

–Peptalk
November 17, 2007

Serum EGFR and HER-2 Expression in Primary and Metastaic Breast Cancer

–Breast Cancer Research
September 07, 2007

Bacterial Contaminant Removal After Purification of Recombinant Protein

–BioProcess International
June 26, 2007

Two-step method to isolate target recombinant protein from co-purified bacterial contaminant SlyD after immobilised metal affinity chromatography

–Journal of Chromatography
March 02, 2007

Autoantibodies in breast cancer: their use as an aid to early diagnosis

–Annals of Oncology
September 22, 2006

Comparison of the autoantibody reactivity of the extracellular and intracellular domains of the tumour antigen HER-2 in breast cancer diagnosis

–Tumor Biology Supplement
September 16, 2006

Serum vs Plasma in autoantibody detection by ELISA

–ISOBM 2006. Pasadena, Calif. for Oncodevelopmental Biology and Medicine, ISOBM 2006 September 16–20, 2006, Pasadena, Calif
September 01, 2006

Autoantibodies in breast cancer: their use as an aid to early diagnosis

–Tumor Biology Supplement
April 16, 2006

Use of autoantibodies in breast cancer screening and diagnosis

–Expert Review of Anticancer Therapy
October 15, 2005

Malignancy-induced autoimmunity to MUC1: initial antibody characterization

–Journal of Peptide Research
October 01, 2005

Autoantibodies in lung cancer

–Tumor Biology Supplement
September 27, 2005

Serum MUC1 O-glycans from cancer patients contain the Sialyl Tn antigen

–Tumor Biology Supplement
September 20, 2005

Human autoantibodies to CA125

–Tumor Biology Supplement